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The objectives of this review were to determine whether the smoking paradox still exists and to summarize 
possible explanations for the smoking paradox. Based on published data, we compared the risk of cigarette 
smoking for lung cancer in Western and Asian countries. We extracted data from the relevant studies about an-
nual tobacco consumption, lung cancer mortality rates according to smoking status from each country, and 
possible explanations for the smoking paradox. A significantly greater risk of lung cancer death was found 
among current smokers in Asian countries than among nonsmokers, with relative risks (RRs) of 4.0 to 4.6 for 
Koreans, 3.7 to 5.1 for Japanese, and 2.4 to 6.5 for Chinese. Although a significantly greater risk of lung can-
cer was present among current smokers in Asian countries, the RRs in Asian countries were much lower than 
those reported in Western countries (range, 9.4 to 23.2). Possible explanations for the smoking paradox includ-
ed epidemiologic characteristics, such as the smoking amount, age at smoking initiation, and the use of filtered 
or mild tobacco. The smoking paradox definitely exists, but may be explained by major epidemiologic charac-
teristics. Therefore, the smoking paradox should not be interpreted as indicating that tobacco is safer or less 
harmful for Asians. 
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INTRODUCTION 
Tobacco has a long history of use starting in the early Ameri-
cas. Following the discovery of tobacco in the New World by 
Christopher Columbus in 1492 [1,2], it was introduced to Eu-
ropean countries. Cigarettes became popular after the Industri-
al Revolution. Tobacco was popularized in two especially signif-
icant periods. The first wave of popularization occurred in West-
ern countries at the time of World War I, which started in 1914. 
The second wave was in Asian countries around the 1940s, an 
epidemic that started 40 years after the European countries. 
Popularization continued until scientific studies in the mid-20th 
century demonstrated the negative health effects of tobacco 
smoking, including lung cancer.
Despite the lack of data for these periods, the prevalence of 
smoking is thought to have increased during World Wars I and 
II. In 1935, corresponding to the development of a machine by 
a British company, the prevalence of smoking increased. The 
tobacco industry requires mass production of cigarettes. The 
first epidemiological paper on this topic published in the first 
half of the 20th century stated that “smoking is connected with 
the shortening of life span,” and smokers began to reflect on 
their health because they observed some negative health effects 
of smoking [3]. In 1950, cigarette companies initiated a shift in 
cigarette design from a non-filter design to a filter design. Pro-
duction of filter cigarettes skyrocketed from 0.5% in 1950 to 
87.7% in 1975 [4]. 
In 1950, Doll & Hill [5] conducted the British Doctors’ Study 
to determine the association between smoking and health con-
sequences. In 1964, the first Surgeon General’s Report was pub-
lished in the US, which allowed governmental enforcement of 
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smoking bans in public places and strongly recommended smok-
ing cessation [6]. Forty years later, another comprehensive re-
port entitled Tobacco Free * Japan was published in 2004 in 
Japan [7]. At that time, findings on smoking and cancer risk ob-
tained using data from the Korean Cancer Prevention Study 
(KCPS) were also published [8]. Interestingly, however, the mag-
nitude of the effect of smoking on lung cancer was different be-
tween Western and Asian countries, with a smaller effect size 
observed in Asian countries. Investigators named this phenom-
enon “the smoking paradox,” and have tried to explain it [9,10]. 
The objectives of this review were to investigate whether the 
smoking paradox still exists and to summarize possible expla-
nations for the smoking paradox (Figure 1). 
DOES THE SMOKING PARADOX EXIST?
To determine whether the risk of smoking for lung cancer is 
lower in Asian countries, which have been referred to as the 
smoking paradox, we reviewed selected well-established epide-
miologic studies from Western and Asian countries. The results 
are presented below. 
United Kingdom
The British Doctors’ Study is the oldest epidemiologic study 
on this topic from the United Kingdom (UK) and has become 
very well known. This UK prospective study of smoking and 
death began in 1950, included 34,439 British male doctors, and 
has now continued for 50 years. The researchers published a 
20-year follow-up study in 1976, a 40-year follow-up in 1994, 
and a 50-year follow-up in 2004 [11-13]. Recently, results from 
a 60-year follow-up study were presented at a meeting in hon-
or of Richard Doll’s centenary at Oxford University on October 
28, 2012. 
In the latest three reports (the 20-year, 40-year, and 50-year 
follow-up) the relative risk (RR) of smoking for lung cancer was 
found to have increased over the duration of follow-up. The RR 
was approximately eight at the time of the 20-year follow-up 
study, but increased to above 14 when the participants were 
followed up for more than 40 years (Figure 2).
US 
In the US, the most well-known prospective cohort that we 
reviewed was the US veterans study [14]. The tobacco use of 
almost 250,000 US veterans was surveyed via questionnaire in 
the 1950s. Together with six other large studies and several case-
control studies, the early results of this investigation provided 
the basis for the first series of reports by the Surgeon General 
on the health effects of smoking, which identified lung cancer 
and a number of other smoking-related diseases [6]. In a graph 
showing the results from the US veterans study cohort published 
in 1995, the RRs of smoking for laryngeal cancer and lung can-
cer were 17.8 and 11.7, respectively [14]. 
Additionally, the Cancer Prevention Study (CPS), the largest 
prospective cohort, was reviewed. In 1959, 1,078,894 subjects 
were recruited by the American Cancer Society to participate 
Figure 1. Landmarks of the history of tobacco, from discovery to popularization.
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Figure 2. Relative risk (RR) of smoking for lung cancer, UK. Adapted 
from Doll et al. [11-13].
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in the 12-year study, CPS-I. CPS-II, a prospective mortality study, 
was initiated by the American Cancer Society in 1982 [15]. The 
American Cancer Society recruited subjects in 1982 among the 
friends, neighbors, and acquaintances of volunteers. The tobac-
co use of almost more than 1.2 million US inhabitants was sur-
veyed by the questionnaire in 1982. The key findings were re-
markable. On average, the mortality among non-smokers was 
8.6, while the mortality among smokers was remarkably high 
(101.3 per 100,000 persons). The estimated RR was 11.9. Smok-
ing accounted for over 95% of lung cancer deaths in men and 
92% in women.
China
China is by far the largest producer of cigarettes in the world. 
Between 1915 and 1945, annual cigarette consumption rose 
from approximately 0 to 100 billion. China is also the largest 
consumer market in the world, with over 300 million smokers 
consuming 1.7 trillion cigarettes in 1997 (unpublished data). 
Three prospective studies of smoking and the RR for lung can-
cer have been conducted: the Shanghai cohort, whose sample 
size was 18,244, and two prospective cohorts studied by Lam 
et al. [16] and Yuan et al. [17]. In the Shanghai cohort, male res-
idents of Shanghai, China were enrolled from January 1, 1986, 
through September 30, 1989 and were actively follow ed via 
annual visits during the study period [17]. However, the cohort 
size was small and the duration of follow-up was relatively short. 
In China, Liu and Peto published a paper [18] presenting a ret-
rospective proportional mortality study of one million deaths 
in 1998. The goal of that study was to examine the hazards at 
an early phase of the growing epidemic of death from tobacco 
in China. From 1989 to 1991, they interviewed the surviving 
family members of one million people who died from 1986 to 
1998 in 98 areas of China. For both sexes, the lung cancer rates 
for individuals 35 to 69 of age were approximately 2.6 times 
higher in smokers than in nonsmokers among men and 2.0 times 
greater in smokers than in non-smokers in women. Of all deaths 
attributed to tobacco, 45% were due to chronic obstructive pul-
monary disease and 15% were due to lung cancer.
Japan
In 2004, Tobacco Free * Japan, a comprehensive and detailed 
report on smoking and health similar to the US Surgeon Gen-
eral’s report was published in Japan. Although the report covered 
numerous epidemiologic studies, we selected the Japan Collab-
orative Cohort (JACC) study for this review [19]. The JACC study 
was sponsored by the Ministry of Education, Culture, Sports, 
Science, and Technology of Japan. The cohort was established 
from 1988 to 1990, with 46,465 men and 64,327 women aged 
40 to 79 years recruited from 45 study areas throughout Japan. 
The RRs for lung cancer in smokers were 4.46 in men and 3.58 
in women. In men, the population-attributable risk (PAR) was 
52.2% for current smokers and 14.8% for ex-smokers.
Korea
In Korea, despite the introduction of tobacco 400 years ago, 
its widespread use in the form of manufactured cigarettes only 
emerged after 1945. The first national brand, produced by a gov-
ernment monopoly, was named Seung Ri, meaning “indepen-
dence from Japan.” Cigarette consumption rose sharply after 
the end of the Korean War in 1953. The rise has been particu-
larly pronounced since 1960, as Korea became economically 
prosperous, with a peak around 2000 (Figure 3) [20]. Korean 
tobacco consumption trends have shown an increase since 1945. 
In Figure 3, the tobacco consumption amount unit is one mil-
lion packs per year, and the red line shows the number of deaths 
from lung cancer. Since 1981, the year of the first mortality re-
port, the number of lung cancer deaths in Korea continuously 
increased until 2015, when a slight drop was observed for the 
first time. The KCPS is a prospective cohort study with a follow-
up period of 24 years that was designed to assess the risk factors 
for mortality, incidence, and hospital admission due to cancer 
and other chronic diseases. The KCPS cohort included 1,329,525 
Koreans from 30 to 88 years of age who underwent biennial 
medical evaluations from 1992 to 1995. The first report based 
on the KCPS was published in 2004. The RRs of smoking for 
lung cancer were 4.6 in men and 2.5 in women [20]. 
Summary of selected publications 
Two major observations were made based on our analysis of 
the data. First, a significantly greater risk of lung cancer mortal-
ity was found among current smokers than among non-smok-
ers in Asian countries (RRs, 4.0 to 4.6 for Koreans; 3.7 to 5.1 
for Japanese; and 2.4 to 6.5 for Chinese). Second, although a 
significantly increased risk of lung cancer was present among 
current smokers in Asian countries, the RRs in Asian countries 
were much lower than those reported in Western countries (range, 
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Figure 3. Tobacco consumption and lung cancer deaths in Korea.
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9.4 to 23.2). The results were very similar among men, with the 
RRs in Asian countries being much lower than those reported 
in Western countries. Asian countries had a lower PAR for smok-
ing and lung cancer than Western countries. In summary, numer-
ous epidemiological studies have consistently reported smoking 
to be a risk factor for lung cancer. However, the magnitude of 
the risk for lung cancer mortality associated with cigarette smok-
ing has been reported to be lower in Asian countries than in West-
ern countries. 
POSSIBLE EXPLANATIONS FOR THE SMOKING 
PARADOX
Different epidemics
Cigarette consumption in Japan and Korea has followed a pat-
tern similar to that observed among adults in the US, although 
the major increase took place 40 years later [7]. One of the possi-
ble explanations for this discrepancy may be the differences in 
the exposure amount of cigarettes smoked in different eras in 
Western countries and Asian countries. The per capita cigarette 
consumption in the US reached 3,000 cigarettes per year in the 
1940s, while Korea and Japan reached the same level in the 1970s. 
Therefore, we may hypothesize that Asian countries have not yet 
experienced the full effect of cigarette smoking on lung cancer. 
Age at smoking initiation and amount of smoking
Another explanation might be the age of smoking initiation. 
It has been found that current smokers in Asian countries began 
smoking at an older age. A strong trend has been found for an 
earlier smoking initiation age in later birth cohorts. While the 
age at smoking initiation for Korean men and women has grad-
ually decreased in recent birth cohorts, they still began smoking 
much later than men and women in the US [20]. The average 
smoking amount among Asian smokers was relatively small in 
the past. In China, the average daily cigarette consumption for 
men was one in 1952, increasing to 16 in 1996 [18]. In Korea, 
the weighted mean of smoking quantity among current smok-
ers was only a half-pack in 1980, which dramatically increased 
to almost one pack in 2000 (unpublished data). 
Toxicity and filter
The contents of tobacco itself have not significantly changed 
over time. Basic physiology and genetic factors are likewise not 
changeable over time. However, tobacco products may have 
changed over time. Since consumer demand has increased for 
mild tobacco due to health concerns, tobacco industries have 
produced products such as Mild Seven or Right, which are known 
to have low tar and low nicotine. Recently, such brands have 
become very popular in Asian countries. Previous studies have 
found that the use of low-nicotine products did not lead smok-
ers to change the quantity of nicotine consumption per day. This 
is because smokers who use low-nicotine products tend to in-
crease the number of cigarettes they smoke to meet their needs 
for nicotine. Therefore, the effects of low-tar or low-nicotine prod-
uct use on various diseases are known to be similar to those of 
standard cigarettes. 
However, Philip Morris, British American Tobacco, and other 
tobacco companies considered the possibility of reducing ciga-
rette toxicity through the use of filters. Although filtered brands 
constitute over 90% of the entire cigarette market [4], epidemi-
ologic data support the conclusion that cigarette filters have done 
little to protect smokers. In 2011, investigators from the US and 
Japan reported that the shift from non-filter to filter cigarettes 
appears to have merely altered the most frequent type of lung 
cancer, from squamous cell carcinoma to adenocarcinoma [21]. 
Lung cancer risk of never smokers
The data previously discussed in this review indicate that lung 
cancer mortality among nonsmokers across countries varies, 
and is likely to be lower in Western countries than in Asian coun-
tries. For men, lung cancer mortality per 100,000 persons among 
non-smokers in Western countries ranged from 14 to 17, while 
in Asians it ranged from 19.2 to 36.0. Death rates of non-smok-
ers in all Asian cohorts were higher than those of non-smokers 
in Western countries. However, the death rates for current smo-
kers in all Asian cohorts were lower than those in Western coun-
tries. Comparing the death rates and exposure levels of current 
smokers indicates that one reason for the lower RR in Asians is 
the presence of higher death rates among non-smokers combined 
with lower death rates among smokers (Figure 4). Another com-
Figure 4. Hypothetical graph of relative risk (RR) in relation to death 
rate and smoking status.
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prehensive study reported that the death rate from lung cancer 
among never smokers was higher in men than in women, and 
higher in Asians residing in Asia than in individuals of Europe-
an descent [22]. This study used participants from the CPS to 
identify mortality rates among those of European descent and 
participants from the KCPS as the Asian sample. The morality 
rates per 100,000 persons among Europeans and Asians were 
12.0 and 26.0 in men and 9.5 and 16.1 in women, respectively. 
One of the possible reasons for the increased lung cancer risk 
among never smokers in Asian countries is poor ventilation com-
bined with the use of coal, which Asian women have traditional-
ly been exposed to [23]. Genetic risk scores involving telomere 
length are also a possible factor explaining differences in lung 
cancer risk among never smokers [24]. 
Genetic differences
The association of DNA methylation with smoking has been 
reported to vary according among ethnic groups [25]. Current 
smokers in Europe have been found to smoke more per day, to 
have started smoking earlier, and, therefore, to have accumulat-
ed more pack-years than South Asians. Differences were found 
in DNA methylation between South Asians (57%) and Europe-
ans (53%) among current smokers. However, the difference was 
not sufficiently large and may not explain the smoking paradox. 
Another issue is epidermal growth factor receptor (EGFR). The 
EGFR gene is a major oncogene in lung cancer adenocarcino-
ma in Asians. The expression of EGFR in both never smokers 
and ever smokers was found to be much higher in Japan than 
in the US [26]. These differences may explain the smoking par-
adox, at least for lung cancer adenocarcinoma in Asians. 
Others
In summary, smoking is the most convincing causal risk fac-
tor for lung cancer, with over 90% of attributable risk in West-
ern countries. Alcohol consumption, cholesterol, total and satu-
rated fat, and animal fat are other possible risk factors. Vegeta-
bles and fruits are convincing protective factors, while physical 
activity, carotenoids, vitamin C, and selenium are potentially 
beneficial. In a report that compared the outcomes of tobacco 
smoking (e.g., lung cancer) between Japan and the US, no dif-
ferences were shown regarding diet, degree of inhalation, or al-
cohol consumption. However, more toxicity due to the carcino-
gens in cigarettes and an earlier onset age of smoking were found 
in the population in the US [27].
CONCLUSION
Based on previous epidemiological studies, the smoking para-
dox definitely exists. However, while the smoking paradox may 
be explained by major epidemiologic differences between West-
ern and Asian populations, such as smoking amount, age at smok-
ing initiation, and the use of filtered or mild tobacco, we cannot 
conclude how much these factors may explain this phenome-
non, as relevant genetic differences have not been sufficiently 
elucidated. 
The smoking paradox itself bears important implications for 
public health. Based on previous studies that examined differ-
ences in epidemiological characteristics related to the smoking 
paradox, the Asian population may not yet have fully experi-
enced the damage from smoking due to a comparably shorter 
tobacco epidemic history than Western countries. Second, the 
Asian population has been found to be characterized by a late 
age of smoking initiation, and since the smoking rate has incre-
ased and the initiation age of adolescents has decreased recent-
ly, the damage from smoking may increase in the future. In the 
public health field, practitioners should be especially cautious 
of misstating the smoking paradox by saying that tobacco is saf-
er or less harmful for Asians. Although tobacco brands change 
over time, the contents of tobacco do not, meaning that no safe 
tobacco brand exists in the world.
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